Primers and Protocols for Standardized Detection of Minimal Residual Disease in Acute Lymphoblastic Leukemia Using Immunoglobulin and T Cell Receptor Gene Rearrangements and Tal1 Deletions as Pcr Targets - Report of the Biomed-1 Concerted Action: Investigation of Minimal Residual Disease in Acute Leukemia